成人疫苗市場：依疫苗類型、技術、應用、分銷管道和地區分類。

2026年成人疫苗市場規模估計為328億美元，預計2033年將達到516億美元。預計2026年至2033年，該市場將以6.69%的複合年成長率成長。

全球成人疫苗市場是預防性醫療保健市場的重要組成部分，旨在為18歲及以上提供免疫接種解決方案和服務。該市場對於預防疫苗可預防疾病和降低醫療保健成本至關重要。

成人疫苗與其他疫苗的不同之處在於，它們根據成人的疾病風險和免疫水平提供相應的免疫接種方案。此細分市場提供多種免疫接種方案，包括流感疫苗、肺炎鏈球菌疫苗、肝炎疫苗、人類乳突病毒（HPV）疫苗、腦膜炎雙球菌疫苗和旅遊疫苗，以及帶狀皰疹疫苗和呼吸道合胞病毒（RSV）疫苗等新型疫苗。

市場成長的促進因素包括：人們對健康保健意識的提高、慢性疾病發生率上升導致免疫力減弱，以及衛生部門擴大疫苗接種建議的範圍。新冠疫情也提高了人們對成人疫苗接種的認知度和接受度，進一步推動了市場成長。此外，包括mRNA在內的新型疫苗技術的研發有望提高疫苗效力，這將進一步刺激市場成長。

市場動態

全球成人疫苗市場受多種因素影響，這些因素共同創造了有利的成長環境。例如，人口老化使得成年人更容易感染疾病、肺炎鏈球菌感染和帶狀皰疹等疾病。此外，糖尿病和心臟病的發生率上升也使成年人更容易受到感染疾病。政府旨在降低醫療成本和推廣預防醫學的措施也產生了顯著影響。國際旅行的增加和職場健康計劃的實施也推動了疫苗需求的成長。此外，疫苗技術的進步提高了疫苗的有效性，並使其更容易被成年人獲得。

然而，阻礙該市場成長的因素包括對疫苗的猶豫、高昂的研發成本以及監管障礙。此外，世界部分地區醫療基礎設施落後也是限制市場成長的主要障礙。

儘管面臨這些挑戰，但新興市場也蘊藏著許多機會，例如醫療基礎設施的改善、可支配收入的增加以及預防醫學的普及。例如，聯合疫苗和數位技術的進步正在提高疫苗的可及性和有效性。

本次調查的主要特點。

• 本報告對全球成人疫苗市場進行了詳細分析，給出了預測期（2026-2033 年）的市場規模（以十億美元計）和複合年成長率（CAGR%），其中 2025 年為基準年。
• 本報告指出了各個細分市場的潛在商機，並說明了該市場中一系列有吸引力的投資提案。
• 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的關鍵見解。
• 本報告根據以下參數對全球成人疫苗市場的主要企業進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
• 透過利用本報告中提出的見解，企業行銷負責人和經營團隊可以就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 本報告面向該產業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過分析全球成人疫苗市場中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章：研究目標與前提條件

• 研究目標
• 前提
• 簡稱

第2章 市場範圍

• 報告摘要
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
• 影響分析
• 主要亮點
• 法規環境
• 產品上市及核准
• PEST分析
• 波特的分析
• 市場機遇
• 法規環境
• 主要進展
• 產業趨勢

第4章 全球成人疫苗市場：依疫苗類型分類，2021-2033年

• 流感
• 肝炎
• 人類乳突病毒（HPV）
• 肺炎球菌
• 破傷風、白喉、百日咳
• COVID-19
• 其他

第5章 全球成人疫苗市場：依技術分類，2021-2033年

• 去活化疫苗、次單位疫苗
• 減毒活病毒疫苗
• 結合疫苗
• 基因改造疫苗
• 藥效疫苗
• 類毒素疫苗

第6章 全球成人疫苗市場：依應用領域分類，2021-2033年

• 預防
• 治療

第7章 全球成人疫苗市場：依通路分類，2021-2033年

• 醫院
• 診所
• 零售藥房
• 政府和公共衛生項目
• 其他

第8章 全球成人疫苗市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 亞太其他地區
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第9章 競爭情勢

• Pfizer Inc
• GlaxoSmithKline plc
• Merck &Co Inc
• Sanofi
• Johnson and Johnson
• Moderna
• AstraZeneca plc
• CSL Limited
• Serum Institute of India
• Bharat Biotech

第10章 分析師建議

• 機會
• 分析師意見
• Coherent Opportunity Map

第11章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

Adult Vaccines Market is estimated to be valued at USD 32.8 Bn in 2026 and is expected to reach USD 51.6 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.69% from 2026 to 2033.

The global adult vaccines market, being a significant segment of the preventive healthcare market, aims at offering immunization solution services to individuals aged 18 years and above. This market segment is vital in the prevention of vaccine-preventable diseases and the reduction of healthcare costs.

Adult vaccines are different in the sense that they offer immunization solution services to individuals based on the risk of acquiring diseases and immunity levels in adults. This market segment offers various immunization solution services, such as influenza, pneumococcal, hepatitis, HPV, meningococcal, and travel vaccines, among other newer vaccines such as shingles and RSV.

The market growth is driven by factors such as the rising awareness of preventive healthcare, the increasing incidence of chronic diseases which compromise immunity, and the widening recommendations for vaccinations by health authorities. The COVID-19 pandemic has also helped raise the awareness and acceptability of adult vaccination, which is further driving the market growth. In addition, the development of new vaccine technologies, including mRNA, is expected to improve the efficacy of vaccines, thereby driving the market growth.

Market Dynamics

The global adult vaccines market is influenced by a number of factors that create a favorable environment for growth. For instance, an aging population is more susceptible to infections like influenza, pneumococcal disease, and shingles. In addition, an increase in diabetes and heart conditions has made adults more susceptible to infections. Government initiatives aimed at cutting healthcare costs and preventive care are also a major influence. Vaccines are also being driven by an increase in international travel and health programs at the workplace. In addition, advances in vaccine technology are making vaccines more effective and accessible to adults.

However, some factors that inhibit growth in this market are vaccine hesitancy, high R&D costs, and regulatory hurdles. In addition, poor healthcare infrastructure in some parts of the world is a major hindrance to growth.

Despite these challenges, some of the opportunities that are available in this market are a growing healthcare infrastructure in emerging markets, a rise in disposable incomes, and an increase in preventive healthcare. For instance, combination vaccines and digital technologies are making vaccines more accessible and effective.

Key Features of the Study

• This report provides in-depth analysis of the global adult vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global adult vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Pfizer Inc, GlaxoSmithKline plc, Merck & Co Inc, Sanofi, Johnson and Johnson, Moderna, AstraZeneca plc, CSL Limited , Serum Institute of India, and Bharat Biotech
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global adult vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global adult vaccines market

Market Segmentation

• Vaccine Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Influenza
  • Hepatitis
  • Human Papillomavirus (HPV)
  • Pneumococcal
  • Tetanus Diphtheria and Pertussis
  • COVID-19
  • Others
• Technology Insights (Revenue, USD Bn, 2021 - 2033)
  • Inactivated and Subunit Vaccines
  • Live Attenuated Vaccines
  • Conjugate Vaccines
  • Recombinant Vaccines
  • mRNA Vaccines
  • Toxoid Vaccines
• Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Preventive
  • Therapeutic
• Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Clinics
  • Retail Pharmacies
  • Government and Public Health Programs
  • Others
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Pfizer Inc
  • GlaxoSmithKline plc
  • Merck & Co Inc
  • Sanofi
  • Johnson and Johnson
  • Moderna
  • AstraZeneca plc
  • CSL Limited
  • Serum Institute of India
  • Bharat Biotech

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Adult Vaccines Market, By Vaccine Type
  • Global Adult Vaccines Market, By Technology
  • Global Adult Vaccines Market, By Application
  • Global Adult Vaccines Market, By Distribution Channel
  • Global Adult Vaccines Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Market Opportunities
• Regulatory Scenario
• Key Developments
• Industry Trends

4. Global Adult Vaccines Market, By Vaccine Type, 2021-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Influenza
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Hepatitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Human Papillomavirus (HPV)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Pneumococcal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Tetanus Diphtheria and Pertussis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• COVID-19
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Adult Vaccines Market, By Technology, 2021-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Inactivated and Subunit Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Live Attenuated Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Conjugate Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Recombinant Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• mRNA Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Toxoid Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Adult Vaccines Market, By Application, 2021-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Preventive
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Therapeutic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Adult Vaccines Market, By Distribution Channel, 2021-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Government and Public Health Programs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Adult Vaccines Market, By Region, 2021 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Pfizer Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlaxoSmithKline plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Johnson and Johnson
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Moderna
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AstraZeneca plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CSL Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Serum Institute of India
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bharat Biotech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us